분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2010-11-08 10:20:31 , Hit : 2632
 Breakthrough in cancer vaccine research

Public release date: 4-Nov-2010
[ Print | E-mail |  Share ] [ Close Window ]

Contact: Genevieve Maul
Genevieve.maul@admin.cam.ac.uk
44-012-237-65542
University of Cambridge


New research could lead to improved vaccines for cancerous tumors
Researchers at the University of Cambridge hope to revolutionise cancer therapy after discovering one of the reasons why many previous attempts to harness the immune system to treat cancerous tumours have failed.

New research, published today in the journal Science, reveals that a type of stromal cell found in many cancers which expresses fibroblast activation protein alpha (FAP), plays a major role in suppressing the immune response in cancerous tumours – thereby restricting the use of vaccines and other therapies which rely on the body's immune system to work. They have also found that if they destroy these cells in a tumour immune suppression is relieved, allowing the immune system to control the previously uncontrolled tumour.

Douglas Fearon, Sheila Joan Smith Professor of Immunology of the Department of Medicine at the University of Cambridge, said: "Finding the specific cells within the complex mixture of the cancer stroma that prevents immune killing is an important step. Further studying how these cells exert their effects may contribute to improved immunological therapies by allowing us to remove a barrier that the cancer has constructed."

Vaccines created to prompt the immune system to attack cancerous cells in tumours have shown to activate an immune response in the body but have, inexplicably, almost never affected the growth of tumours. Immunologists who specialise in tumours have suspected that within the tumour microenvironment the activity of immune cells is somehow suppressed, but they have thus far been unable to fully reverse this suppression.

The new research, funded by the Wellcome Trust and the Sheila Joan Smith Professorship endowment, sheds light on why the immune response is suppressed. The Cambridge study found that at least one immune suppressive component is contained within normal tissue cells (called stromal cells) the cancer has coerced to assist its survival. The cell they studied specifically expresses a unique protein often associated with wound healing - fibroblast activation protein alpha (FAP). The FAP expressing cells are found in many cancers, including breast and colorectal cancers.

In order to determine if FAP expressing stromal cells contribute to the resistance of a tumour to vaccination, the researchers created a transgenic mouse model which allowed them to destroy cells which expressed FAP. When FAP-expressing cells were destroyed in tumours in mice with established Lewis lung carcinomas (of which only 2% of the tumour cells are FAP-expressing), the cancer began to rapidly 'die'. The Fearon lab now hopes to collaborate with scientists at the CRUK Cambridge Research Institute to evaluate the effects of depleting FAP-expressing cells in a mouse model that more closely resemble human cancer, and to examine FAP-expressing cells of human tumours.

Professor Fearon continued: "These studies are in the mouse, and although there is much overlap between the mouse and human immune systems, we will not know the relevance of these findings in humans until we are able to interrupt the function of the tumour stromal cells expressing FAP in patients with cancer.

"It should be noted, however, that the FAP-expressing stromal cell was actually first found in human cancer by Lloyd Old and his colleagues 20 years ago."


###
For additional information please contact:
Genevieve Maul, Office of Communications, University of Cambridge
Tel: direct, +44 (0) 1223 765542, +44 (0) 1223 332300
Mob: +44 (0) 7774 017464
Email: Genevieve.maul@admin.cam.ac.uk








967   Strides Against Hepatitis C Open Door to Blockbusters  이성욱 2010/11/02 2519
966   Black patients fare well on Vertex hepatitis C drug  이성욱 2010/11/02 2655
965   NC State Develops More Precise Genetic ‘Off Switches’  이성욱 2010/11/03 2591
  Breakthrough in cancer vaccine research  이성욱 2010/11/08 2632
963   DNA sequence may be lost in translation  이성욱 2010/11/10 2738
962   Lung Cancer in Smokers, Nonsmokers May Be a Different Disease  이성욱 2010/11/10 2539
961   Why brain tumors hard to treat  이성욱 2010/11/23 2879
960   Vertex submits application for hepatitis C drug  이성욱 2010/11/25 3386
959   Tumours grow their own blood vessels  이성욱 2010/11/25 2307
958   Top 5 papers of 2010  이성욱 2010/12/10 2288
957   Microbe gets toxic response  이성욱 2010/12/10 2423
956   Basel Declaration defends animal research  이성욱 2010/12/10 2315
955   Missing Molecules Hold Promise of Therapy for Pancreatic Cancer: Lost microRNAs Put Brakes on Tumors  이성욱 2010/12/22 2210
954   HIV patient with leukemia treated through stem cell transplant  이성욱 2010/12/23 4967
953   Top 5 papers of 2010  이성욱 2010/12/28 2549
952   Smoking May Worsen Pain For Cancer Patients  이성욱 2010/12/28 2654
951   key interaction in hepatitis C virus  이성욱 2010/12/30 2207
950   Parallels Between Cancers, Infection Suppression: Same Proteins Involved, but Cancer Takes Hold When Response Gets out of Control  이성욱 2011/01/11 2566
949   Cancer Can Develop in Catastrophic Burst  이성욱 2011/01/13 2809
948   Viral Evasion Gene Reveals New Targets for Eliminating Chronic Infections  이성욱 2011/01/17 2298

[이전 10개] [1]..[11][12][13][14][15] 16 [17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN